L3Harris Technologies Work in process increased by 6.2% to $309.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.5%, from $349.00M to $309.00M. Over 5 years (FY 2021 to FY 2026), Work in process shows a downward trend with a -4.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $292.00M | $325.00M | $335.00M | $326.00M | $403.00M | $464.00M | $396.00M | $463.00M | $486.00M | $513.00M | $427.00M | $436.00M | $383.00M | $375.00M | $332.00M | $349.00M | $323.00M | $327.00M | $291.00M | $309.00M |
| QoQ Change | — | +11.3% | +3.1% | -2.7% | +23.6% | +15.1% | -14.7% | +16.9% | +5.0% | +5.6% | -16.8% | +2.1% | -12.2% | -2.1% | -11.5% | +5.1% | -7.4% | +1.2% | -11.0% | +6.2% |
| YoY Change | — | — | — | — | +38.0% | +42.8% | +18.2% | +42.0% | +20.6% | +10.6% | +7.8% | -5.8% | -21.2% | -26.9% | -22.2% | -20.0% | -15.7% | -12.8% | -12.3% | -11.5% |
| % of Inventories | 33.5% | 31.7% | 34.1% | 29.9% | 32.5% | 34.7% | 30.7% | 30.0% | 31.3% | 31.3% | 29.0% | 29.5% | 26.7% | 26.8% | 25.0% | 27.9% | 25.7% | 25.3% | 23.9% | 25.0% |
| Share Change | — | -1.7pp | +2.4pp | -4.2pp | +2.6pp | +2.2pp | -4.0pp | -0.6pp | +1.2pp | +0.1pp | -2.3pp | +0.5pp | -2.8pp | +0.1pp | -1.8pp | +2.9pp | -2.2pp | -0.3pp | -1.5pp | +1.2pp |